These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3020411)

  • 1. Structure-activity relationship and pharmacology of the highly selective mu-opioid agonist, morphiceptin.
    Chang KJ
    NIDA Res Monogr; 1986; 69():101-11. PubMed ID: 3020411
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.
    Fichna J; do-Rego JC; Costentin J; Chung NN; Schiller PW; Kosson P; Janecka A
    Biochem Biophys Res Commun; 2004 Jul; 320(2):531-6. PubMed ID: 15219861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid peptides: analysis of specificity and multiple binding modes through computer-aided drug design and structure-activity studies.
    Nelson RD; Gottlieb DI; Balasubramanian TM; Marshall GR
    NIDA Res Monogr; 1986; 69():204-30. PubMed ID: 3020414
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
    Ward SJ; LoPresti D; James DW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic structure-activity studies of peptide and nonpeptide flexible opioids: an interdisciplinary approach.
    Loew GH; Toll L; Uyeno E; Cheng A; Judd A; Lawson J; Keys C; Amsterdam P; Polgar W
    NIDA Res Monogr; 1986; 69():231-65. PubMed ID: 3020415
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
    Nishino K; Su YF; Wong CS; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endogenous polypeptides with morphine-like activity (enkephalins, endorphins, anodynin) (a review of the literature)].
    Chickenkov ON
    Farmakol Toksikol; 1978; 41(2):245-56. PubMed ID: 26593
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of conformationally constrained cyclic peptides with high delta and mu opioid receptor specificities.
    Hruby VJ
    NIDA Res Monogr; 1986; 69():128-47. PubMed ID: 3020412
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of mu, delta and kappa receptors in morphine-induced tolerance in the guinea pig myenteric plexus.
    Leedham JA; Bennett LE; Taylor DA; Fleming WW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):295-301. PubMed ID: 1656024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A; James IF
    Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: a quantitative autoradiography approach.
    Gouarderes C; Jhamandas K; Zajac JM; Beaudet A; Cros J; Quirion R
    Prog Clin Biol Res; 1990; 328():175-8. PubMed ID: 2154775
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-melanocyte stimulating hormone inhibits the contractile action of a mu opioid agonist in the isolated colon of the rat.
    Kramer TH; Davis P; Burks TF
    Proc West Pharmacol Soc; 1988; 31():17-9. PubMed ID: 2850555
    [No Abstract]   [Full Text] [Related]  

  • 20. The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand.
    Zhang AZ; Chang JK; Pasternak GW
    Life Sci; 1981 Jun; 28(25):2829-36. PubMed ID: 6267398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.